Mutations in the gene for the hemoglobin protein result in a group of hereditary diseases termed the hemoglobinopathies, the most common members of which are sickle cell anaemia and thalassaemia.
Primary component of origin
Percent of component
Approximately 33%
Production
Endogenous hemoglobin is produced in the bone marrow and built into the cell lines that eventually become red blood cells.
Pharmaceutical preparations of hemoglobin are extracted from sequestered (separated) human or bovine blood.
Medicinal Value
Whether administered by means of donor blood substitutes, hemoglobin therapy is the most direct and fast acting means of correcting anemia.
Risks
Pharmaceuticals, found in
Hemopure, Polyheme.
Alternatives
Recombinant human erythropoietin (EPO) plus oral or intravenous iron, folic acid, vitamin B12,and vitamin K, to encourage the bone marrow to step up the production of red blood cells.








Sections




Rate this article